Risks with continuous subcutaneous insulin infusion can be serious [4]

British Medical Journal

Volumn 323, Issue 7314, 2001, Pages 693-694

  Knight, G ^a  

^a ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

CONTINUOUS INFUSION; DIABETES MELLITUS; DISEASE COURSE; DRUG COST; DRUG RESPONSE; DRUG SAFETY; HEART ARREST; HUMAN; KETOACIDOSIS; LETTER; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

DIABETIC KETOACIDOSIS; HUMANS; HYPOGLYCEMIC AGENTS; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, PARENTERAL; INSULIN;

EID: 0035934632     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Continuous subcutaneous insulin infusion in type 1 diabetes
2. Frequency of diabetic ketoacidosis and hypogiycaemic coma during treatment with continuous subcutaneous insulin infusion
3. Severe hyperkalaemia and ketoacidosis during routine treatment with an insulin pump